Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Artivion Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS
Ticker
Exchange
SIC #
Website
Latest Ticker
AORT
New York
3841
https://artivion.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Artivion Inc
Artivion to Participate in the Oppenheimer 33rd Annual Healthcare Conference
- Mar 6th, 2023 9:10 pm
Artivion Reports Fourth Quarter and Full Year 2022 Financial Results
- Feb 16th, 2023 9:05 pm
Artivion Announces Release Date and Teleconference Call Details for Fourth Quarter and Full Year 2022 Financial Results
- Feb 2nd, 2023 1:30 pm
Artivion (AORT) Upgraded to Buy: What Does It Mean for the Stock?
- Nov 25th, 2022 5:00 pm
Wall Street Analysts Think Artivion (AORT) Could Surge 79%: Read This Before Placing a Bet
- Nov 25th, 2022 2:55 pm
Wall Street Analysts Predict a 173% Upside in Artivion (AORT): Here's What You Should Know
- Nov 9th, 2022 2:55 pm
Artivion to Participate in Upcoming Investor Conferences
- Nov 8th, 2022 9:25 pm
Artivion Reports Third Quarter 2022 Financial Results
- Nov 3rd, 2022 8:05 pm
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2022 Financial Results
- Oct 20th, 2022 12:25 pm
Elizabeth Hoff Joins Artivion Board of Directors
- Sep 29th, 2022 8:10 pm
Artivion Follows Recommendation to Stop PROACT Xa Clinical Trial
- Sep 23rd, 2022 11:00 am
Artivion to Present at the Deutsche Bank 30th Annual Leveraged Finance Conference
- Sep 14th, 2022 12:10 pm
Artivion to Present at the Gilmartin Group Emerging Growth Company Showcase
- Aug 24th, 2022 8:10 pm
Artivion Reports Second Quarter 2022 Financial Results
- Aug 4th, 2022 8:05 pm
What Makes Artivion (AORT) a New Buy Stock
- Jul 29th, 2022 4:00 pm
Artivion Initiates Enrollment in PERSEVERE Clinical Trial
- Jul 27th, 2022 12:25 pm
Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2022 Financial Results
- Jul 21st, 2022 12:25 pm
Artivion to Participate in the UBS 2022 Global Healthcare Conference
- May 16th, 2022 12:25 pm
Further weakness as Artivion (NYSE:AORT) drops 24% this week, taking three-year losses to 48%
- May 12th, 2022 6:55 pm
Artivion Reports First Quarter 2022 Financial Results
- May 5th, 2022 8:05 pm
Scroll